Bucks guard Damian Lillard is no longer taking blood thinner medication for deep vein thrombosis and is cleared for full basketball activities, the team announced Thursday, opening the door for a potential return during Milwaukee’s first-round playoff series against the Indiana Pacers.
Lillard was diagnosed with deep vein thrombosis in his right calf, the Bucks announced on March 25.
“We’re thrilled for Dame,” said Bucks General Manager Jon Horst on Thursday. “Our priority has always been Dame’s health. We’re grateful to our medical team for diagnosing and treating his DVT at an early stage, and for the world-renown hematology specialists at Mayo Clinic. Every step of Dame’s recovery has been at the direction of world-class medical professionals and their specific and strict protocols that have allowed for Dame’s safe and healthy return to play.”
Lillard will continue to increase his on-court basketball activity in preparation for his return to play.
Lillard averaged 24.9 points, 7.1 assists and 4.7 rebounds in 58 for games for Milwaukee this season, and Lillard and All-Star Giannis Antetokounmpo were the highest-scoring duo in the league. The Bucks were 32-26 with Lillard in the lineup and were 10-4 without him in the final three weeks of the season.
The USA TODAY app gets you to the heart of the news — fast. Download for award-winning coverage, crosswords, audio storytelling, the eNewspaper and more.
